Moxetumomab pasudotox and Risperidone Injection (IM)
Determining the interaction of Moxetumomab pasudotox and Risperidone Injection (IM) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: risperidone
Brand name: Risperdal, Perseris, Risperdal Consta, Risperdal Consta, Risperdal M-Tab
Synonyms: Risperidone, RisperiDONE
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Risperidone Injection (Subcutaneous)
- Moxetumomab pasudotox-Risperidone Intramuscular
- Moxetumomab pasudotox-RisperiDONE M-Tab
- Moxetumomab pasudotox-Risperidone Oral Solution
- Moxetumomab pasudotox-Risperidone Orally Disintegrating
- Moxetumomab pasudotox-Risperidone Orally Disintegrating Tablets
- Risperidone Injection (IM)-Moxetumomab Pasudotox-tdfk
- Risperidone Injection (IM)-Moxetumomab pasudotox-tdfk Intravenous
- Risperidone Injection (IM)-Moxifloxacin
- Risperidone Injection (IM)-Moxifloxacin (Systemic)
- Risperidone Injection (IM)-Moxifloxacin Hydrochloride
- Risperidone Injection (IM)-Moxifloxacin Injection